Sofinnova Partners
European venture capital firm founded in 1972 focused on life sciences and sustainability. Sofinnova Partners manages over €4 billion, has backed 500+ companies, and operates a multi-fund platform across seed to later-stage investments. The firm emphasises long-term, hands-on partnerships, company creation and sector-specialist teams across healthcare and industrial sustainability.
Sofinnova Partners
Paris, Ile-de-France, France, Europe
Services
Equity financing
Provides equity financing to startups and early-stage companies across seed to later-stage through multiple dedicated funds and strategies.
Medtech accelerator (MD Start)
In-house medtech accelerator offering hands-on company building and operational support to early-stage medtech ventures.
Company building & operational support
Hands-on support for company creation and development including strategic guidance, operational input and management-level assistance.
Sector-specialist investment teams and review
Applications and opportunities are reviewed by teams of experts dedicated to each sector / fund strategy to align investments to expertise.
Later-stage financing and crossover support
Support and financing for later-stage biotech and medtech companies to enable scale and exit readiness through the Crossover strategy.
Industrial biotech support
Early-stage investment and business development support for industrial biotech ventures focused on sustainability in chemicals, agriculture, food and materials.
Equity financing
Provides equity financing to startups and early-stage companies across seed to later-stage through multiple dedicated funds and strategies.
Medtech accelerator (MD Start)
In-house medtech accelerator offering hands-on company building and operational support to early-stage medtech ventures.
Company building & operational support
Hands-on support for company creation and development including strategic guidance, operational input and management-level assistance.
Sector-specialist investment teams and review
Applications and opportunities are reviewed by teams of experts dedicated to each sector / fund strategy to align investments to expertise.
Later-stage financing and crossover support
Support and financing for later-stage biotech and medtech companies to enable scale and exit readiness through the Crossover strategy.
Industrial biotech support
Early-stage investment and business development support for industrial biotech ventures focused on sustainability in chemicals, agriculture, food and materials.
Portfolio
Subject of acquisition by Johnson & Johnson (news item referenced).
#Medical Devices
FDA IND clearance for Phase I/II clinical trial announced (news).
#Biopharmaceuticals
Subject of acquisition by Johnson & Johnson (news item referenced).
#Medical Devices
FDA IND clearance for Phase I/II clinical trial announced (news).
#Biopharmaceuticals